Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Malabsorption Syndromes D008286 16 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Thrombasthenia D013915 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Arthus Reaction D001183 8 associated lipids
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lenshof A and Laurell T Emerging clinical applications of microchip-based acoustophoresis. 2011 J Lab Autom pmid:22093301
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Semini G et al. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. 2011 Pharmacogenet. Genomics pmid:21681147
Khan BQ and Kemp SF Pathophysiology of anaphylaxis. 2011 Curr Opin Allergy Clin Immunol pmid:21659865
Lacy P et al. Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. 2011 Int. Arch. Allergy Immunol. pmid:21576984
Howard KM et al. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways. 2011 Inflamm. Res. pmid:21432021
Jönsson F et al. Mouse and human neutrophils induce anaphylaxis. 2011 J. Clin. Invest. pmid:21436586
Côrte-Real R et al. The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus. 2011 J. Insect Physiol. pmid:21439293
Li XJ et al. [Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance]. 2011 Zhonghua Bing Li Xue Za Zhi pmid:21426810
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Xu LF et al. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. 2011 Arch. Pharm. Res. pmid:21380808
Orlando RC et al. Esophageal disease: updated information on inflammation. 2011 Ann. N. Y. Acad. Sci. pmid:21950828
Cureton EL et al. Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. 2011 J. Appl. Physiol. pmid:21183623
Liu J et al. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. 2011 Circ. Res. pmid:21183738
Soares PM et al. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. 2011 Cancer Chemother. Pharmacol. pmid:21153821
Zimmermann LT et al. Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus. 2011 Parasitol. Res. pmid:21161276
Musto AE and Samii M Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. 2011 Epilepsia pmid:21204830
Liao HJ et al. Two new ginkgolides from the leaves of Ginkgo biloba. 2011 Planta Med. pmid:21614751
Lowry P 1-O-alkenyl-sn-glyceryl-3-phosphorylcholine may be a novel posttranslational modification used by the placenta. 2011 Biopolymers pmid:20564011
Kennedy MA et al. Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor. 2011 PLoS Genet. pmid:21347278
Kim HA et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression. 2011 Cell. Physiol. Biochem. pmid:21325822
Saihkay HN et al. Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. 2011 Jan-Feb J Pharmacol Toxicol Methods pmid:20646985
Cingi C et al. The histopathological effect of thymoquinone on experimentally induced rhinosinusitis in rats. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185737
Nordin N et al. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. 2012 Pharm Biol pmid:22103812
Tanaka Y et al. Stimulation of Ly-6G on neutrophils in LPS-primed mice induces platelet-activating factor (PAF)-mediated anaphylaxis-like shock. 2012 J. Leukoc. Biol. pmid:22131343
Shi W et al. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components. 2012 J. Thorac. Cardiovasc. Surg. pmid:22079877
Detopoulou P et al. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics. 2012 Prostaglandins Other Lipid Mediat. pmid:22079887
Ding DD et al. [Changes of platelet α-particle membrane protein, platelet activating factor and platelet parameters in patients with hyperuricemia]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22541106
Camuesco D et al. The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis. 2012 Br. J. Pharmacol. pmid:21790535
Sahu RP et al. The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. 2012 Carcinogenesis pmid:22542595
Sato A et al. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor. 2012 Eur. J. Pharmacol. pmid:22542654
Bachi AL et al. Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor. 2012 Mediators Inflamm. pmid:22577252
Nitoda E et al. Ocular actions of platelet-activating factor: clinical implications. 2012 Expert Opin. Ther. Targets pmid:22924390
Sahu RP et al. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. 2012 Carcinogenesis pmid:22223848
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces alkaline phosphatase release, CD63 expression, F-actin polymerization and chemotaxis without affecting the phagocytosis activity in bovine neutrophils. 2012 Vet. Immunol. Immunopathol. pmid:22226550
Dumas E et al. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. 2012 Biochim. Biophys. Acta pmid:22198097
López-Sagaseta J et al. sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove. 2012 Blood pmid:22167755
Park J et al. Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes. 2012 Int. J. Mol. Med. pmid:22211242
Bae R et al. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells. 2012 Int. Arch. Allergy Immunol. pmid:22212397
Widgerow AD and Kalaria S Pain mediators and wound healing--establishing the connection. 2012 Burns pmid:22738827
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. 2012 Thromb. Haemost. pmid:22318645
Zhang XT et al. [Study on the pharmacokinetics of ginkgolide B for injection in rats]. 2012 Zhong Yao Cai pmid:22876684
Flamm MH et al. Multiscale prediction of patient-specific platelet function under flow. 2012 Blood pmid:22517902
Kim HA et al. PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis. 2012 FEBS Lett. pmid:23137704
Jiang Z et al. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. 2012 Respir. Res. pmid:23140447
Senbagavalli P et al. Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytes. 2012 Clin. Vaccine Immunol. pmid:23100480
Zhang J et al. Traumatic brain injury-associated coagulopathy. 2012 J. Neurotrauma pmid:23020190
Zia-Ul-Haq M et al. Report: Platelet aggregation inhibition activity of selected legumes of Pakistan. 2012 Pak J Pharm Sci pmid:23010006
Tsoupras AB et al. Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients. 2012 Angiology pmid:21948973
Juchem G et al. Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22081707